Adverse effects: pain on injection (solution deposition), Heft-Parker VAS 0-170 mm · adults and children undergoing general anaesthesia including the muscle relaxant rocuronium bromide
Adverse effects of pharmacological intervention showed no clear difference in pain on injection compared with control (low certainty).
1 finding from 1 review
Adherence to inhaled therapies cMPR · children, adolescents or adults with CF
Summary of findings: psychological interventions probably leads to higher adherence to inhaled therapies: % of prescribed inhaled therapies… compared with usual care (moderate certainty).
1 finding from 1 review
QoL · adults (aged 16 years and over) with CF
1 finding from 1 review
FEV1 % predicted · adults (aged 16 years and over) with CF
1 finding from 1 review
Pulmonary exacerbations · adults (aged 16 years and over) with CF
1 finding from 1 review
Treatment‐related adverse events Anxiety: GAD‐7 (Spitzer 2006) · children, adolescents or adults with CF
Summary of findings: psychological interventions showed no clear difference in treatment‐related adverse events Anxiety: GAD‐7 (Spitzer 2006) compared with usual care (low certainty).
1 finding from 1 review
Treatment‐related adverse events Depression PHQ‐8 (Kroenke 2009) · children, adolescents or adults with CF
Summary of findings: psychological interventions showed no clear difference in treatment‐related adverse events Depression PHQ‐8 (Kroenke 2009) compared with usual care (low certainty).
1 finding from 1 review
QoL · children, adolescents or adults with CF
Summary of findings: psychological interventions may leads to higher qoL CFQ‐R (Quittner 2009) compared with usual care (low certainty).
1 finding from 1 review
FEV1 % predicted · children, adolescents or adults with CF
Summary of findings: psychological interventions showed no clear difference in lung function FEV1 % predicted compared with usual care (moderate certainty).
1 finding from 1 review
Pulmonary exacerbations · children, adolescents or adults with CF
1 finding from 1 review
Adherence to inhaled therapies cMPR · adults (aged 16 years and over) with CF
1 finding from 1 review
Anxiety (adverse effect, post‐intervention) · adults (aged 16 years and over) with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment‐related adverse events Depression · adults (aged 16 years and over) with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression or PTSD recovery · children/adolescents with post‐traumatic stress and related depressive/anxiety symptoms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease prevalence · children/adolescents with post‐traumatic stress and related depressive/anxiety symptoms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · children/adolescents with post‐traumatic stress and related depressive/anxiety symptoms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Service utilisation · children/adolescents with post‐traumatic stress and related depressive/anxiety symptoms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total sleep time, next day ‐ main sleep time only; · Shift workers
1 finding from 1 review
Total sleep time, next day ‐ 24‐hr sleep time, including naps; · Shift workers
1 finding from 1 review
Sleep efficiency · Shift workers
1 finding from 1 review